Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma

References

• ChengTYCrambSMBaadePDYouldenDRNwoguCReidMEThe International epidemiology of lung cancer: latest trends, disparities, and tumor characteristicsJ Thorac Oncol201611101653167127364315
   PubMed Web of Science ®Google Scholar
• RocaEGurizzanCAmorosoVVermiWFerrariVBerrutiAOutcome of patients with lung adenocarcinoma with transformation to small-cell lung cancer following tyrosine kinase inhibitors treatment: a systematic review and pooled analysisCancer Treat Rev20175911712228806542
   PubMed Web of Science ®Google Scholar
• TorreLASiegelRLJemalALung cancer statisticsAdv Exp Med Biol201689311926667336
   PubMed Web of Science ®Google Scholar
• ZhangYLvYNiuYSuHFengARole of circulating tumor cell (CTC) monitoring in evaluating prognosis of triple-negative breast cancer patients in ChinaMed Sci Monit2017233071307928643770
   PubMed Web of Science ®Google Scholar
• XuTShenGChengMXuWShenGHuSClinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysisOncotarget2017837625246253628977966
   PubMedGoogle Scholar
• WuWZhangZGaoXHClinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH)Oncotarget2017813216392164928423493
   PubMedGoogle Scholar
• LiuWYinBWangXCirculating tumor cells in prostate cancer: precision diagnosis and therapyOncol Lett20171421223123228789337
   PubMed Web of Science ®Google Scholar
• YangDWangLTianXApplication of circulating tumor cells scope technique on circulating tumor cell researchMol Cell Ther20142826056577
   PubMedGoogle Scholar
• KallergiGPolitakiEAlkahtaniSStournarasCGeorgouliasVEvaluation of isolation methods for circulating tumor cells (CTCs)Cell Physiol Biochem2016403–441141927889762
   PubMedGoogle Scholar
• VilaAAbalMMuinelo-RomayLEGFR-based immunoisolation as a recovery target for low-EpCAM CTC subpopulationPLoS One20161110e016370527711186
   PubMed Web of Science ®Google Scholar
• LeeMKimEJChoYPredictive value of circulating tumor cells (CTCs) captured by microfluidic device in patients with epithelial ovarian cancerGynecol Oncol2017145236136528274569
   PubMed Web of Science ®Google Scholar
• KangYTDohIByunJChangHJChoYHLabel-free rapid viable enrichment of circulating tumor cell by photosensitive polymer-based microfilter deviceTheranostics20177133179319128900503
   PubMed Web of Science ®Google Scholar
• ZhouMDHaoSWilliamsAJSeparable bilayer microfiltration device for viable label-free enrichment of circulating tumour cellsSci Rep20144739225487434
   PubMed Web of Science ®Google Scholar
• RanRLiLWangMWangSZhengZLinPPDetermination of EGFR mutations in single cells microdissected from enriched lung tumor cells in peripheral bloodAnal Bioanal Chem2013405237377738223828210
   PubMed Web of Science ®Google Scholar
• LiYQLiuYSYingXWLentivirus-mediated disintegrin and metalloproteinase 17 RNA interference reversed the acquired resistance to gefitinib in lung adenocarcinoma cells in vitroBiotechnol Prog Epub2017927
   Web of Science ®Google Scholar
• MitsudomiTKosakaTYatabeYBiological and clinical implications of EGFR mutations in lung cancerInt J Clin Oncol200611319019816850125
   PubMedGoogle Scholar
• LeeDHSrimuninnimitVChengRWangXOrlandoMEpidermal growth factor receptor mutation status in the treatment of non-small cell lung cancer: lessons learnedCancer Res Treat201547454955425943319
   PubMed Web of Science ®Google Scholar
• LynchTJBellDWSordellaRActivating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinibN Engl J Med2004350212129213915118073
   PubMed Web of Science ®Google Scholar
• XuMXieYNiSLiuHThe latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC)Ann Transl Med2015379626015938
   PubMedGoogle Scholar
• LiangZChengYChenYEGFR T790M ctDNA testing platforms and their role as companion diagnostics: correlation with clinical outcomes to EGFR-TKIsCancer Lett201740318619428642172
   PubMed Web of Science ®Google Scholar
• TakamochiKOhSMatsunagaTSuzukiKPrognostic impacts of EGFR mutation status and subtype in patients with surgically resected lung adenocarcinomaJ Thorac Cardiovasc Surg201715451768.e11774.e128826599
   PubMed Web of Science ®Google Scholar
• CourtCMAnkenyJSShoSReality of single circulating tumor cell sequencing for molecular diagnostics in pancreatic cancerJ Mol Diagn201618568869627375074
   PubMed Web of Science ®Google Scholar
• SchneckHBlasslCMeier-StiegenFAnalysing the mutational status of PIK3CA in circulating tumor cells from metastatic breast cancer patientsMol Oncol20137597698623895914
   PubMed Web of Science ®Google Scholar
• ZhangCWeiBLiPPrognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIsPLoS One2017123e017352428333951
   PubMed Web of Science ®Google Scholar
• SiegelRMaJZouZJemalACancer statistics, 2014CA Cancer J Clin201464192924399786
   PubMed Web of Science ®Google Scholar
• LinCCHuangWLWeiFSuWCWongDTEmerging platforms using liquid biopsy to detect EGFR mutations in lung cancerExpert Rev Mol Diagn201515111427144026420338
   PubMed Web of Science ®Google Scholar
• FuruyamaKHaradaTIwamaESensitivity and kinase activity of epidermal growth factor receptor (EGFR) exon 19 and others to EGFR-tyrosine kinase inhibitorsCancer Sci2013104558458923387505
   PubMed Web of Science ®Google Scholar
• CappuzzoFMorabitoANormannoNEfficacy and safety of rechallenge treatment with gefitinib in patients with advanced non-small cell lung cancerLung Cancer201699313727565910
   PubMed Web of Science ®Google Scholar
• LiWRenSLiJT790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patientsLung Cancer201484329530024685306
   PubMed Web of Science ®Google Scholar
• GiacconeGEGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancerNat Clin Pract Oncol20052629629716264986
   PubMedGoogle Scholar